August 9, 2018 / 4:10 PM / 4 months ago

BRIEF-Camber Pharmaceuticals Issues Voluntary Nationwide Recall Of Valsartan Tablets

Aug 9 (Reuters) - Camber Pharmaceuticals Inc:

* CAMBER PHARMACEUTICALS, INC. ISSUES VOLUNTARY NATIONWIDE RECALL OF VALSARTAN TABLETS, USP, 40MG, 80MG, 160MG AND 320MG.

* CAMBER PHARMACEUTICALS - TO DATE, CAMBER HAS NOT RECEIVED ANY REPORTS OF ADVERSE EVENTS RELATED TO VALSARTAN TABLETS RECALL Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below